Galmed Pharmaceuticals
GLMD
#9945
Rank
NZ$7.94 M
Marketcap
$4.79
Share price
-5.41%
Change (1 day)
-32.82%
Change (1 year)

EPS for Galmed Pharmaceuticals (GLMD)

EPS in 2023 (TTM): -$11.15

According to Galmed Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$11.45. In 2022 the company made an earnings per share (EPS) of -$18.09 an increase over its 2021 EPS that were of -$33.90.

EPS history for Galmed Pharmaceuticals from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$11.15-38.37%
2022-$18.09-46.62%
2021-$33.90-2.22%
2020-$34.6739.18%
2019-$24.9170.18%
2018-$14.64-41.84%
2017-$25.16-34.23%
2016-$38.2656.84%
2015-$24.399.2%
2014-$22.34-53.43%
2013-$47.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$2.21-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-$6.88-39.91%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
-$1.28-88.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.04-64.72%๐Ÿ‡บ๐Ÿ‡ธ USA